Yungjin, Ildong face redemption suit of medication costs

Published: 2008-09-05 06:55:00

Updated: 2008-09-05 06:55:00

The National Health Insurance Corporation filed a suit against Yungjin Pharm and Ildong Pharm, for their improper health insurance allowance claim of medicines involved in fabricated bioequivalence test results.

“The two pharmaceutical firms should pay back 290 million won to the NHIC,” a NHIC...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK